VEGF as a potential target for therapeutic intervention in depression.

Abstract:

:Antidepressants are among the most widely prescribed drugs, however the mechanism underlying their therapeutic efficacy is not known. Neurotrophic factors represent a promising class of targets for antidepressant treatments. We recently characterized a role for vascular endothelial growth factor (VEGF) in cellular and behavioral antidepressant responses. VEGF is a potent mitogen and survival factor for endothelial cells (ECs) and neurons, and modulator of synaptic transmission. Because VEGF has been implicated in a variety of diseases, understanding the molecular and cellular specificity of antidepressant-induced VEGF will be crucial to determine its potential as a therapeutic target in depression.

journal_name

Curr Opin Pharmacol

authors

Warner-Schmidt JL,Duman RS

doi

10.1016/j.coph.2007.10.013

subject

Has Abstract

pub_date

2008-02-01 00:00:00

pages

14-9

issue

1

eissn

1471-4892

issn

1471-4973

pii

S1471-4892(07)00184-1

journal_volume

8

pub_type

杂志文章,评审
  • Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis.

    abstract::Pseudomonas aeruginosa is an opportunistic pathogen that significantly contributes to morbidity and mortality in patients with cystic fibrosis. Defective mucociliary clearance associated with the absence of the functional cystic fibrosis transmembrane conductance regulator in airway epithelium plays a critical role in...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.12.005

    authors: Gómez MI,Prince A

    更新日期:2007-06-01 00:00:00

  • Clinically validated peptides as templates for de novo peptidomimetic drug design at G-protein-coupled receptors.

    abstract::Recent advances in the development of potent and selective peptide and non-peptide ligands for peptidergic receptors are anticipated to help further unravel the roles of class I and II G-protein-coupled receptors in the pathogenesis of human diseases and to accelerate the clinical utility of small molecule peptidomime...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2003.06.003

    authors: Jones RM,Boatman PD,Semple G,Shin YJ,Tamura SY

    更新日期:2003-10-01 00:00:00

  • Regulators of G protein signalling: a spotlight on emerging functions in the cardiovascular system.

    abstract::Regulator of G protein signalling (RGS) proteins are GTPase-activating proteins for heterotrimeric G protein alpha subunits, and are therefore physiologically and pathophysiologically important negative regulators of G-protein-coupled receptor signalling in the cardiovascular system. Owing to the functional redundancy...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.11.007

    authors: Wieland T,Lutz S,Chidiac P

    更新日期:2007-04-01 00:00:00

  • Therapeutic potential of marine n-3 fatty acids in CABG patients.

    abstract::Dietary intake of marine n-3 polyunsaturated fatty acids (PUFA) has beneficial effects in various cardiac disorders. Few studies have, however, investigated the therapeutic potential of n-3 PUFA in patients undergoing coronary artery bypass grafting (CABG). Five heterogeneous randomized studies on n-3 PUFA for prevent...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2012.01.012

    authors: Andreasen JJ,Schmidt EB

    更新日期:2012-04-01 00:00:00

  • Psychotropic agents in functional gastrointestinal disorders.

    abstract::Functional gastrointestinal disorders (FGIDs) are common conditions diagnosed by established symptom-based criteria. Dysregulation of the brain-gut axis is emerging as the primary pathophysiologic mechanism for FGIDs; this opens avenues for newer treatment modalities. Psychotropic agents act on a variety of neurotrans...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2008.07.012

    authors: Grover M,Drossman DA

    更新日期:2008-12-01 00:00:00

  • The roles of cyclic nucleotide phosphodiesterases (PDEs) in steroidogenesis.

    abstract::The second messenger, cAMP, is one of the most important regulatory signals for control of steroidogenesis. This review focuses on current knowledge about regulation of cyclic nucleotides by phosphodiesterases (PDEs) in steroidogenic tissues. The first PDE known to directly regulate steroidogenesis was PDE2, the cGMP-...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2011.09.003

    authors: Tsai LC,Beavo JA

    更新日期:2011-12-01 00:00:00

  • Pulmonary hypertension: inhaled nitric oxide, sildenafil and natriuretic peptides.

    abstract::Phosphodiesterase-5 (PDE5) inhibitors and other agents that modulate intracellular cGMP are now emerging as promising, safe, and easy to administer therapies for pulmonary hypertension, with relatively few side effects. Recent studies have shown that PDE5 inhibitors are potent acute pulmonary vasodilators in experimen...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2004.12.008

    authors: Steiner MK,Preston IR,Klinger JR,Hill NS

    更新日期:2005-06-01 00:00:00

  • Antibody therapy for rheumatoid arthritis.

    abstract::High-quality monoclonal antibodies (mAbs) with specificity for relevant disease molecules can now be produced in abundance. Anti-tumour necrosis factor-alpha therapies have set a new standard for symptom control in rheumatoid arthritis, and blockade of tumour necrosis factor has the potential to protect joints from st...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(03)00032-8

    authors: Taylor PC

    更新日期:2003-06-01 00:00:00

  • 5-HT(6) receptor and cognition.

    abstract::Since its discovery in 1993 and subsequent development of selective antagonists, a growing number of studies support the use of serotonin 5-HT(6) receptor antagonism as a promising mechanism for treating cognitive dysfunction. Lately, several studies with structurally different compounds have shown that not only antag...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2011.01.004

    authors: Codony X,Vela JM,Ramírez MJ

    更新日期:2011-02-01 00:00:00

  • Antibacterials in the pipeline and perspectives for the near future.

    abstract::Antimicrobial resistance is a global threat to the management of infections in our patients. Sound stewardship of antibacterial agents at our disposal must be accompanied by a concerted effort to develop new agents to bolster our armamentarium. This review will cover the latest antibiotics that have come through the p...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2019.05.001

    authors: Gould IM,Gunasekera C,Khan A

    更新日期:2019-10-01 00:00:00

  • Biased ligands: pathway validation for novel GPCR therapeutics.

    abstract::G protein-coupled receptors (GPCRs), in recent years, have been shown to signal via multiple distinct pathways. Furthermore, biased ligands for some receptors can differentially stimulate or inhibit these pathways versus unbiased endogenous ligands or drugs. Biased ligands can be used to gain a deeper understanding of...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.04.002

    authors: Rominger DH,Cowan CL,Gowen-MacDonald W,Violin JD

    更新日期:2014-06-01 00:00:00

  • Putative druggable targets for selective enhancement of cardiac conduction.

    abstract::Putative druggable targets to selectively enhance cardiac conduction can be considered from the level of the ion channels determining the initiation and duration of the cardiac action potential to the gap junction proteins responsible for optimal cellular electrical coupling. Nature has provided a number of inherited ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章

    doi:10.1016/j.coph.2008.11.008

    authors: Gomes J,Lambiase PD

    更新日期:2009-04-01 00:00:00

  • Immunomodulation in stem-cell transplantation.

    abstract::Acute graft-versus-host disease is a complication that affects 30-60% of patients undergoing allogeneic stem-cell transplantation. The standard for prophylaxis for graft-versus-host disease has historically been the combination of cyclosporine and methotrexate. Recently, tacrolimus has been used more frequently and cu...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00174-1

    authors: Abo-Zena RA,Horwitz ME

    更新日期:2002-08-01 00:00:00

  • Drug delivery to the upper small intestine window using gastroretentive technologies.

    abstract::The bioavailability of drugs with an absorption window in the upper small intestine is generally limited with conventional pharmaceutical dosage forms. The residence time of such systems and, thus, of their drug release into the stomach and upper intestine is often short. To overcome this restriction and to increase t...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.04.007

    authors: Streubel A,Siepmann J,Bodmeier R

    更新日期:2006-10-01 00:00:00

  • The role of tissue factor/factor VIIa in the pathophysiology of acute thrombotic formation.

    abstract::Tissue factor (TF) is the essential cofactor for the coagulation protease factor VIIa (FVIIa), initiating the coagulation cascade. The role of TF in thrombotic diseases is becoming increasingly evident. Recent findings suggest that inhibition of TF/FVIIa activity could be important in the prevention of clinical sequel...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(01)00031-5

    authors: Girard TJ,Nicholson NS

    更新日期:2001-04-01 00:00:00

  • Understanding the pharmacology of stroke and multiple sclerosis through imaging.

    abstract::Stroke and multiple sclerosis (MS) illustrate how clinical imaging can facilitate early phase drug development and most effective medicine use in the clinic. Imaging has enhanced understanding of the dynamics of evolution of disease pathophysiology, better defining treatment targets. Imaging measures can enable strati...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2013.10.006

    authors: Matthews PM,Geraghty OC

    更新日期:2014-02-01 00:00:00

  • Monoclonal antibodies as a strategy for pulmonary diseases.

    abstract::Monoclonal antibodies have been used successfully to elucidate the roles of putative mediators of pulmonary disease. In particular, clinical trials with monoclonal antibodies directed against interleukin-5, IgE or CD4 yielded results that were critical in dissecting the pathophysiology of asthma; but, more importantly...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(01)00047-9

    authors: Torphy TJ,Li L,Griswold DE

    更新日期:2001-06-01 00:00:00

  • Recent advances in combinatorial drug screening and synergy scoring.

    abstract::Treatment of complex diseases such as cancer, cardiovascular disease, diabetes or neurological disorders frequently warrants the utilization of drug combinations for therapeutic intervention. In fact, the most successful example is the current standard of care for HIV patients. However, identification of successful dr...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2018.07.008

    authors: Pemovska T,Bigenzahn JW,Superti-Furga G

    更新日期:2018-10-01 00:00:00

  • Angiotensin type 2 receptors: blood pressure regulation and end organ damage.

    abstract::In most situations, the angiotensin AT2-receptor (AT2R) mediates physiological actions opposing those mediated by the AT1-receptor (AT1R), including a vasorelaxant effect. Nevertheless, experimental evidence vastly supports that systemic application of AT2R-agonists is blood pressure neutral. However, stimulation of A...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2015.01.004

    authors: Sumners C,de Kloet AD,Krause EG,Unger T,Steckelings UM

    更新日期:2015-04-01 00:00:00

  • New and emerging anti-fibrotic therapeutics entering or already in clinical trials in chronic liver diseases.

    abstract::Chronic liver diseases with different etiologies represent a major public health issue worldwide. Liver fibrosis is the common feature of almost all chronic liver diseases and remains a key determinant of clinical prognosis. Over the last two decades, basic science studies have uncovered molecular mechanisms underlyin...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2019.09.006

    authors: Lemoinne S,Friedman SL

    更新日期:2019-12-01 00:00:00

  • The application of in vitro surveillance data for antibacterial dose selection.

    abstract::In vitro surveillance data, which provide key information to interpret the results of pharmacokinetic/pharmacodynamics (PK-PD) target attainment studies, are used to support dose selection decisions and recommendations for in vitro susceptibility testing criteria for antibacterial agents during drug development. Consi...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2017.10.009

    authors: Flamm RK,Sader HS,Castanheira M,Jones RN

    更新日期:2017-10-01 00:00:00

  • TNF-alpha in asthma.

    abstract::Although only 5-10% of patients with asthma are relatively unresponsive to treatment with inhaled corticosteroids, refractory asthma represents an important condition, as these patients suffer considerable morbidity and mortality and consume a disproportionately large amount of health resource. Treatment options are l...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2007.03.001

    authors: Berry M,Brightling C,Pavord I,Wardlaw A

    更新日期:2007-06-01 00:00:00

  • Pharmacology on microfluidics: multimodal analysis for studying cell-cell interaction.

    abstract::Understanding the mechanisms of cell-cell interaction is a key unanswered question in modern pharmacology, given crosstalk defects are at the basis of many pathologies. Microfluidics represents a valuable tool for analyzing intercellular communication mediated by transmission of soluble signals, as occurring for examp...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2013.07.005

    authors: Delamarche E,Tonna N,Lovchik RD,Bianco F,Matteoli M

    更新日期:2013-10-01 00:00:00

  • Mechanisms of resistance in estrogen receptor positive breast cancer: overcoming resistance to tamoxifen/aromatase inhibitors.

    abstract::Several mechanisms of resistance have been identified, underscoring the complex nature of estrogen receptor (ER) signaling and the many connections between this pathway and other essential signaling pathways in breast cancer cells. Many therapeutic targets of cell signaling and cell cycle pathways have met success wit...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2018.04.009

    authors: Mills JN,Rutkovsky AC,Giordano A

    更新日期:2018-08-01 00:00:00

  • Mechanism of action of general anaesthetics--new information from molecular pharmacology.

    abstract::Major progress in our understanding of the mechanisms of anaesthesia has been made during the past year. Several key advances in defining very specific sites of action on ligand-gated ion channels have been described. Furthermore, new techniques have become available for addressing the identification of binding sites ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(01)00013-3

    authors: Thompson SA,Wafford K

    更新日期:2001-02-01 00:00:00

  • Targeting the mitochondria to augment myocardial protection.

    abstract::The dynamic regulation of the structure, function and turnover of mitochondria is recognized as an immutable control node maintaining cellular integrity and homeostasis. The term 'mitohormesis' has recently been coined to describe the adaptive reprogramming of mitochondrial biology in response to low levels of metabol...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2007.12.008

    authors: Schwartz DR,Sack MN

    更新日期:2008-04-01 00:00:00

  • 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action.

    abstract::11beta-hydroxysteroid dehydrogenases (11beta-HSDs) catalyse the interconversion of active cortisol and inert cortisone. Two isozymes have been discovered, each with unique properties and powerful biological roles. 11beta-HSD2 potently inactivates cortisol, protecting key tissues. By contrast, 11beta-HSD1 regenerates c...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2004.09.001

    authors: Seckl JR

    更新日期:2004-12-01 00:00:00

  • Skeletal muscle as an immunogenic organ.

    abstract::During the past few years, a possible link between skeletal muscle contractile activity and immune changes has been established. This concept is based on the finding that exercise provokes an increase in a number of cytokines. We have suggested that cytokines and other peptides that are produced; expressed and release...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2008.02.005

    authors: Nielsen S,Pedersen BK

    更新日期:2008-06-01 00:00:00

  • Osteocytes: The master cells in bone remodelling.

    abstract::Bone remodelling is an essential process for shaping and maintaining bone mass in the mature skeleton. During our lifetime bone is constantly being removed by osteoclasts and new bone is formed by osteoblasts. The activities of osteoclasts and osteoblasts must be regulated under a strict balance to ensure that bone ho...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2016.02.003

    authors: Prideaux M,Findlay DM,Atkins GJ

    更新日期:2016-06-01 00:00:00

  • Platelet purinergic receptors.

    abstract::Activation of P2Y(1) and P2Y(12) receptors, through secreted ADP that is stimulated by agonists such as thrombin, thromboxane and collagen, is a major mechanism of platelet activation. P2X(1) receptors also participate in platelet shape change and potentiation of calcium mobilization. The cloning of the P2Y(12) recept...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(03)00007-9

    authors: Kunapuli SP,Dorsam RT,Kim S,Quinton TM

    更新日期:2003-04-01 00:00:00